NO20054908D0 - Fremgangsmate for findeling og stabilisering av sma partikler i suspensjon - Google Patents

Fremgangsmate for findeling og stabilisering av sma partikler i suspensjon

Info

Publication number
NO20054908D0
NO20054908D0 NO20054908A NO20054908A NO20054908D0 NO 20054908 D0 NO20054908 D0 NO 20054908D0 NO 20054908 A NO20054908 A NO 20054908A NO 20054908 A NO20054908 A NO 20054908A NO 20054908 D0 NO20054908 D0 NO 20054908D0
Authority
NO
Norway
Prior art keywords
comminuting
suspension
small particles
stabilizing small
stabilizing
Prior art date
Application number
NO20054908A
Other languages
English (en)
Other versions
NO20054908L (no
Inventor
James E Kipp
Joseph Chung Tak Wong
Monte Wisler
Rhonda Garcia
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of NO20054908D0 publication Critical patent/NO20054908D0/no
Publication of NO20054908L publication Critical patent/NO20054908L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924Significant dispersive or manipulative operation or step in making or stabilizing colloid system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/924Significant dispersive or manipulative operation or step in making or stabilizing colloid system
    • Y10S516/925Phase inversion
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Colloid Chemistry (AREA)
NO20054908A 2003-03-24 2005-10-24 Fremgangsmate for findeling og stabilisering av sma partikler i suspensjon NO20054908L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45742403P 2003-03-24 2003-03-24
US10/806,050 US7511079B2 (en) 2003-03-24 2004-03-22 Methods and apparatuses for the comminution and stabilization of small particles
PCT/US2004/009242 WO2004084860A2 (en) 2003-03-24 2004-03-24 Methods for the comminution and stabilization of small particles in suspension

Publications (2)

Publication Number Publication Date
NO20054908D0 true NO20054908D0 (no) 2005-10-24
NO20054908L NO20054908L (no) 2005-12-21

Family

ID=33101285

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054908A NO20054908L (no) 2003-03-24 2005-10-24 Fremgangsmate for findeling og stabilisering av sma partikler i suspensjon

Country Status (10)

Country Link
US (1) US7511079B2 (no)
EP (1) EP1605915A2 (no)
JP (1) JP2006521396A (no)
KR (1) KR20050115298A (no)
AU (1) AU2004224307A1 (no)
BR (1) BRPI0408707A (no)
CA (1) CA2519536A1 (no)
MX (1) MXPA05010045A (no)
NO (1) NO20054908L (no)
WO (1) WO2004084860A2 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2500065A1 (en) * 2002-09-30 2004-04-15 Acusphere, Inc. Sustained release porous microparticles for inhalation
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US7511079B2 (en) 2003-03-24 2009-03-31 Baxter International Inc. Methods and apparatuses for the comminution and stabilization of small particles
US20050069591A1 (en) * 2003-09-30 2005-03-31 Howard Bernstein Injectable, oral, or topical sustained release pharmaceutical formulations
JP5080445B2 (ja) * 2005-04-13 2012-11-21 アボット ゲーエムベーハー ウント コー. カーゲー 超微粒子懸濁液及び超微粒子を穏やかに製造する方法並びにその使用
DE102005053862A1 (de) * 2005-11-04 2007-05-10 Pharmasol Gmbh Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
US8946200B2 (en) * 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
US8282266B2 (en) 2007-06-27 2012-10-09 H R D Corporation System and process for inhibitor injection
US20090187135A1 (en) * 2008-01-18 2009-07-23 Eilaz Babaev Ultrasonic syringe
US8404850B2 (en) * 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8187554B2 (en) * 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
US8722706B2 (en) * 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) * 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
US9028873B2 (en) * 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
US10350556B2 (en) 2011-01-07 2019-07-16 Microfluidics International Corporation Low holdup volume mixing chamber
US9199209B2 (en) 2011-04-13 2015-12-01 Microfluidics International Corporation Interaction chamber with flow inlet optimization
US9079140B2 (en) 2011-04-13 2015-07-14 Microfluidics International Corporation Compact interaction chamber with multiple cross micro impinging jets
CA2895529C (en) * 2012-12-19 2018-08-21 Kashiv Pharma, Llc Supersaturated stabilized nanoparticles for poorly soluble drugs
JP6462403B2 (ja) * 2015-02-23 2019-01-30 大川原化工機株式会社 湿式分散器
EP3664785A4 (en) 2018-06-22 2022-01-12 Delphi Scientific, LLC APPARATUS, SYSTEMS, AND METHODS FOR CONTINUOUS MANUFACTURING OF NANOMATERIALS AND HIGH-PURITY CHEMICALS
WO2020041631A1 (en) * 2018-08-22 2020-02-27 Avalyn Pharma Inc. Specially formulated compositions of inhaled nintedanib and nintedanib salts

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3685261A (en) * 1971-02-16 1972-08-22 Environeering Wet scrubber for contaminated gas
US4908154A (en) 1981-04-17 1990-03-13 Biotechnology Development Corporation Method of forming a microemulsion
CA1282405C (en) 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
JP3282731B2 (ja) 1990-06-15 2002-05-20 メルク エンド カムパニー インコーポレーテッド 結晶の構造および大きさを改良する結晶化方法
DE4241549A1 (de) * 1992-12-10 1994-06-16 Nied Roland Verfahren und Vorrichtung für die Prallzerkleinerung von Feststoffpartikeln
JPH07328471A (ja) * 1994-06-06 1995-12-19 Furukawa Co Ltd 粉砕装置
US5720551A (en) 1994-10-28 1998-02-24 Shechter; Tal Forming emulsions
SE9403846D0 (sv) 1994-11-09 1994-11-09 Univ Ohio State Res Found Small particle formation
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5833891A (en) 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
JPH10137618A (ja) * 1996-11-14 1998-05-26 Ritsumeikan 微細粒子製造方法
US6159442A (en) 1997-08-05 2000-12-12 Mfic Corporation Use of multiple stream high pressure mixer/reactor
EP1037713B1 (en) 1997-12-17 2002-07-10 Universidad de Sevilla Method of producing hollow droplets
US6086376A (en) 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
JP2934229B1 (ja) * 1998-05-14 1999-08-16 清二 加川 固液混合流体の破砕・分散装置
US8293277B2 (en) 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6610317B2 (en) 1999-05-27 2003-08-26 Acusphere, Inc. Porous paclitaxel matrices and methods of manufacture thereof
DE10007816A1 (de) 2000-02-21 2001-09-06 Bayer Ag Verfahren zur Herstellung von Nanosuspensionen
AU2001257115B2 (en) 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
DE60140625D1 (de) 2000-08-15 2010-01-07 Univ Illinois Verfahren zur herstellung von mikropartikeln
AU2002249836B2 (en) * 2000-12-22 2006-12-14 Baxter International Inc. Method for preparing submicron particle suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
JP2003001079A (ja) * 2001-06-18 2003-01-07 Karasawa Fine Ltd 粒子微細化装置
US7511079B2 (en) 2003-03-24 2009-03-31 Baxter International Inc. Methods and apparatuses for the comminution and stabilization of small particles

Also Published As

Publication number Publication date
EP1605915A2 (en) 2005-12-21
US7511079B2 (en) 2009-03-31
AU2004224307A1 (en) 2004-10-07
WO2004084860A3 (en) 2005-03-24
US20040266890A1 (en) 2004-12-30
MXPA05010045A (es) 2005-10-26
JP2006521396A (ja) 2006-09-21
KR20050115298A (ko) 2005-12-07
BRPI0408707A (pt) 2006-03-07
WO2004084860A2 (en) 2004-10-07
NO20054908L (no) 2005-12-21
CA2519536A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
NO20054908D0 (no) Fremgangsmate for findeling og stabilisering av sma partikler i suspensjon
HK1089155A1 (en) Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
IL229509A0 (en) Preparations containing chemically modified small molecules and processes using them
IL184313A0 (en) 4-(1h-indol-3-yl)-pyrimidin-2-ylamine derivates and their use in therapy
IL176089A0 (en) Modified macromolecules and methods of making and using thereof
AU2003243260A8 (en) Microstructured taggant particles, applications and methods of making the same
EP1846751A4 (en) METHODS AND DEVICES FOR CHARACTERIZING PARTICLES IN CLEAR AND DISORDER MEDIA
IL185578A0 (en) Method and system for laser marking in the volume of gemstones such as diamonds
EP1915463A4 (en) NANOPARTICLES DESIGNED FOR HANDLING BIOPOLYMERS AND ASSOCIATED METHODS
IL174788A0 (en) Indolinone derivatives and their use in treating disease-states such as cancer
GB0515801D0 (en) Time in databases and applications of databases
DE60319925D1 (de) Verringerung des Ausflusses von Partikeln in Bohrlöchern
AU2003287663A1 (en) Mram and methods for reading the mram
EP1597921A4 (en) APPARATUS AND METHODS FOR PAGING
DK3246399T3 (da) Alfavirus-partikler og fremgangsmåder til fremstilling
EP1691661A4 (en) SOLUBLE TCR MOLECULES AND APPLICATION METHODS
IL166535A0 (en) Modified adamts4 molecules and method of use thereof
DE602004002735D1 (de) Mesoporöse Kieselsäureteilchen und deren Herstellungsprozess
NO20045141D0 (no) Silikabelagte polymerpartikler, fremgangsmate for fremstilling og anvendelse derav
HK1131882A1 (en) Educated nkt cells and their uses in the treatment of immune-related disorders
GB0311026D0 (en) Organisation representation framework and design process
PL1658237T3 (pl) Sposób rozdrabniania cząstek substancji organicznych w zawiesinach mikroorganizmów
DE602004026831D1 (de) Polymerteilchenzusammensetzung und herstellungsverfahren dafür
EP1590440A4 (en) CELL-KILLING MOLECULES AND METHODS FOR THEIR USE
FR2852021B1 (fr) Methodes et outils pour le criblage d'arn actifs in cellulo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application